Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ

Abstract Although ductal carcinoma in situ (DCIS) is a non-obligate precursor to ipsilateral invasive breast cancer (iIBC), most DCIS lesions remain indolent. Hence, overdiagnosis and overtreatment of DCIS is a major concern. There is an urgent need for prognostic markers that can distinguish harmle...

Full description

Bibliographic Details
Main Authors:	Mathilde M. M. Almekinders, Michael Schaapveld, Bram Thijssen, Lindy L. Visser, Tycho Bismeijer, Joyce Sanders, Edoardo Isnaldi, Ingrid Hofland, Marjolijn Mertz, Lodewyk F. A. Wessels, Annegien Broeks, Erik Hooijberg, Wilbert Zwart, Esther H. Lips, Grand Challenge PRECISION Consortium, Christine Desmedt, Jelle Wesseling
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-03-01
Series:	npj Breast Cancer
Online Access:	https://doi.org/10.1038/s41523-021-00232-w

Similar Items

Molecular characterization of breast and lung tumors by integration of multiple data types with functional sparse-factor analysis.
by: Tycho Bismeijer, et al.
Published: (2018-10-01)

Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivo
by: Yongsoo Kim, et al.
Published: (2019-11-01)

Genome-wide epigenetic profiling of breast cancer tumors treated with aromatase inhibitors
by: Ekaterina Nevedomskaya, et al.
Published: (2014-12-01)

Multi-marker detection approach for improving breast cancer treatment tailoring
by: Desmedt, Christine
Published: (2008)

Multi-marker detection approach for improving breast cancer treatment tailoring
by: Desmedt, Christine
Published: (2008)

Quality of life in patients with metastatic breast cancer : A South African perspective
by: Mertz, Magaretha Susara
Published: (2013)

Breast cancer subtype specific classifiers of response to neoadjuvant chemotherapy do not outperform classifiers trained on all subtypes.
by: Jorma J de Ronde, et al.
Published: (2014-01-01)

Variability in grading of ductal carcinoma in situ among an international group of pathologists
by: Maartje vanSeijen, et al.
Published: (2021-05-01)

Does Physical Activity Have an Impact on Recurrence Dynamics in Early Breast Cancer Patients?
by: Elia Biganzoli, et al.
Published: (2021-02-01)

Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.
by: Marie Gosset, et al.
Published: (2016-01-01)

Fibromatosis (desmoid tumor) of the breast mimicking a case of ipsilateral metachronous breast cancer
by: Jimenez Rafael E, et al.
Published: (2006-08-01)

Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification
by: Mieke R. Van Bockstal, et al.
Published: (2020-04-01)

Keratinocytic epidermal nevus with ipsilateral breast hypoplasia
by: Eric Chen, BS, et al.
Published: (2019-07-01)

Evolutionary Trajectories and Genomic Divergence in Localized Breast Cancers after Ipsilateral Breast Tumor Recurrence
by: Chia-Hsin Wu, et al.
Published: (2021-04-01)

FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome
by: Willemijne Schrijver, et al.
Published: (2018-11-01)

Becker nevus syndrome presented with ipsilateral breast hypoplasia
by: Suzan Demir Pektas, et al.
Published: (2014-01-01)

The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors
by: Heleen K. Bronsveld, et al.
Published: (2018-02-01)

Discordance between Primary Breast Cancer and Ipsilateral Breast Cancer Tumor Recurrence as a Function of Distance
by: Sebastian M. Jud, et al.
Published: (2020-12-01)

Approximating multivariate posterior distribution functions from Monte Carlo samples for sequential Bayesian inference.
by: Bram Thijssen, et al.
Published: (2020-01-01)

Late effects of adjuvant chemotherapy adumbrate dormancy complexity in breast cancer
by: Romano Demicheli, et al.
Published: (2020-08-01)

Types of Mastectomies and Immediate Reconstructions for Ipsilateral Breast Local Recurrences
by: Pauline Simon, et al.
Published: (2020-12-01)

Transient ipsilateral breast edema following COVID-19 vaccination
by: Dodelzon, K., et al.
Published: (2022)

Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases.
by: Marieke A Vollebergh, et al.
Published: (2014-01-01)

Second breast conserving therapy after ipsilateral breast tumor recurrence – a 10-year experience of re-irradiation
by: Tobias Forster, et al.
Published: (2019-08-01)

Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer?
by: Schaapveld Michael, et al.
Published: (2011-06-01)

Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up
by: Guilherme Freire Angotti Carrara, et al.

The Structures of Conceptual Transformation in the European Space
by: Mathijs Almekinders
Published: (2020-12-01)

Module-based outcome prediction using breast cancer compendia.
by: Martin H van Vliet, et al.
Published: (2007-01-01)

New Primary Ipsilateral Metachronous Breast Tumor: A Case Report
by: Silvia Cuerda, et al.
Published: (2012-10-01)

Ipsilateral breast tumour relapse: local recurrence versus new primary and the effect of whole breast radiotherapy on the rate of new primaries
by: Gujral, D.M, et al.
Published: (2011)

The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation
by: Yuka Ono, et al.
Published: (2019-07-01)

Comparison of prognostic gene expression signatures for breast cancer
by: van't Veer Laura, et al.
Published: (2008-08-01)

Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy
by: Nicola S. Russell, et al.
Published: (2017-12-01)

BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
by: Esther H. Lips, et al.
Published: (2020-07-01)

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.
by: Marcelo Sobral-Leite, et al.
Published: (2017-01-01)

Case of Primary Breast and Ipsilateral Axillary T-Cell Lymphoma: a Rare Occurrence
by: Faryal Afridi, et al.
Published: (2020-01-01)

Recurrence and mortality according to Estrogen Receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast
by: Ferraris Cristina, et al.
Published: (2010-11-01)

Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
by: Tesa M. Severson, et al.
Published: (2018-02-01)

How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research
by: Leigh Pate, et al.
Published: (2021-06-01)

Breast Cancer and Breast Reconstruction
Published: (2020)